{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Analgesia Regimens for Esophagectomy"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed using sealed envelopes."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included adult patients scheduled for minimally invasive esophagectomy. The study was conducted in a tertiary care hospital."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either EA or PVB."
      },
      "Objective": {
        "score": 1,
        "evidence": "To compare the effectiveness of EA and PVB in reducing postoperative pain and complications."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was postoperative pain measured by the Numeric Rating Scale (NRS) over 48 hours."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 200 participants were randomised: 100 to the EA group and 100 to the PVB group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the EA group and 97 in the PVB group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The mean difference in NRS scores was 0.89 (95% CI: \u22120.47 to 2.24; p = 0.21)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included hypotension and urinary retention in the EA group (3%) and none in the PVB group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678"
      },
      "Funding": {
        "score": 1,
        "evidence": "This trial was funded by the National Institute of Health."
      }
    },
    "total_score": 22,
    "max_score": 25
  },
  "model": "gpt-4o"
}